Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2025-12-25 @ 2:55 AM
NCT ID:
NCT07041333
Eligibility Criteria:
Inclusion Criteria:
1. According to DSM-5 TR, the participant must have a diagnosis of "Attention Deficit Hyperactivity Disorder" and have started/be planning to start routine methylphenidate treatment.
2. The participant must be between 6 and 11 years of age.
3. The participant must agree to participate in the study after being informed about it.
Exclusion Criteria:
1. The presence of a psychiatric disorder diagnosis other than Attention Deficit Hyperactivity Disorder
2. Having a diagnosis of Attention Deficit Hyperactivity Disorder but not planning to start methylphenidate
3. Being under 6 years of age or over 11 years of age
4. Having organic brain damage, mental retardation, autism spectrum disorder, neurological disease, or a physical illness that affects neurocognitive functions
5. History of alcohol and/or psychoactive substance use
6. Presence of ongoing active infection, allergic disease, and chronic illness
7. Previous use of psychiatric medication.
8. Presence of chronic illness
9. Regular use of medication
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
11 Years
Study:
NCT07041333
Study Brief:
Protocol Section:
NCT07041333